Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis Article

Jelcic, I, Al Nimer, F, Wang, J et al. (2018). Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis . 175(1), 85-100.e23. 10.1016/j.cell.2018.08.011

cited authors

  • Jelcic, I; Al Nimer, F; Wang, J; Lentsch, V; Planas, R; Jelcic, I; Madjovski, A; Ruhrmann, S; Faigle, W; Frauenknecht, K; Pinilla, C; Santos, R; Hammer, C; Ortiz, Y; Opitz, L; Grönlund, H; Rogler, G; Boyman, O; Reynolds, R; Lutterotti, A; Khademi, M; Olsson, T; Piehl, F; Sospedra, M; Martin, R

abstract

  • Multiple sclerosis is an autoimmune disease that is caused by the interplay of genetic, particularly the HLA-DR15 haplotype, and environmental risk factors. How these etiologic factors contribute to generating an autoreactive CD4+ T cell repertoire is not clear. Here, we demonstrate that self-reactivity, defined as “autoproliferation” of peripheral Th1 cells, is elevated in patients carrying the HLA-DR15 haplotype. Autoproliferation is mediated by memory B cells in a HLA-DR-dependent manner. Depletion of B cells in vitro and therapeutically in vivo by anti-CD20 effectively reduces T cell autoproliferation. T cell receptor deep sequencing showed that in vitro autoproliferating T cells are enriched for brain-homing T cells. Using an unbiased epitope discovery approach, we identified RASGRP2 as target autoantigen that is expressed in the brain and B cells. These findings will be instrumental to address important questions regarding pathogenic B-T cell interactions in multiple sclerosis and possibly also to develop novel therapies. Memory B cells drive proliferation of self-reactive brain-homing CD4+ T cells, which recognize autoantigens expressed in B cells and in brain lesions with target potential in multiple sclerosis.

publication date

  • September 20, 2018

Digital Object Identifier (DOI)

start page

  • 85

end page

  • 100.e23

volume

  • 175

issue

  • 1